JF
AUPH icon

Jump Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Jump Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.8M Buy
+165,000
New +$2.64M 0.02% 750
2026
Q1 		– Sell
-127,774
Closed -$2.04M – 1883
2025
Q4 		$2.04M Sell
127,774
-368,539
-74% -$5.22M 0.03% 675
2025
Q3 		$5.48M Buy
496,313
+106,212
+27% +$1.16M 0.07% 378
2025
Q2 		$3.3M Buy
390,101
+339,377
+669% +$2.72M 0.04% 552
2025
Q1 		$408K Buy
+50,724
New +$411K 0.01% 1163
2024
Q4 		– Sell
-189,955
Closed -$1.39M – 1633
2024
Q3 		$1.39M Buy
+189,955
New +$1.18M 0.03% 657
2023
Q4 		– Sell
-17,109
Closed -$133K – 1777
2023
Q3 		$133K Sell
17,109
-7,168
-30% -$70.1K ﹤0.01% 1631
2023
Q2 		$235K Sell
24,277
-9,077
-27% -$94.2K 0.01% 1442
2023
Q1 		$366K Buy
+33,354
New +$294K 0.01% 1030
2022
Q3 		– Sell
-133,853
Closed -$1.34M – 1573
2022
Q2 		$1.34M Buy
133,853
+11,353
+9% +$127K 0.06% 463
2022
Q1 		$1.52M Buy
+122,500
New +$1.89M 0.06% 364
2021
Q3 		– Sell
-44,700
Closed -$579K – 1094
2021
Q2 		$579K Buy
+44,700
New +$569K 0.06% 427
2020
Q4 		– Sell
-34,500
Closed -$508K – 941
2020
Q3 		$508K Buy
+34,500
New +$500K 0.1% 323

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jump Financial's AUPH Position: Q2 2026 in Review

Jump Financial opened a new position in Aurinia Pharmaceuticals (AUPH) in Q2 2026: 165,000 shares worth $2.8M. The stake represents 0.02% of the portfolio and ranks #750 among its holdings. This is a return to the name: Jump Financial previously reported a position in AUPH as recently as Q4 2025.

Jump Financial first reported a position in AUPH in Q3 2020 and has held it in 13 quarters since. The position peaked at $5.48M in Q3 2025. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Jump Financial held 165,000 shares of Aurinia Pharmaceuticals worth $2.8M as of Q2 2026.
  • Aurinia Pharmaceuticals was a new Jump Financial position in Q2 2026.
  • Aurinia Pharmaceuticals made up 0.02% of Jump Financial's portfolio in Q2 2026, its #750 holding.
  • Jump Financial first reported a position in Aurinia Pharmaceuticals in Q3 2020 and has held it in 13 quarters since.
  • Jump Financial's Aurinia Pharmaceuticals position peaked at $5.48M in Q3 2025.
  • 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.